SHL Group grows through medical devices

By Steve Toloken
Staff Reporter / Asia Bureau Chief

Published: February 13, 2014 3:24 pm ET
Updated: February 13, 2014 3:30 pm ET

Frank Isaksson, left, and Steven Kaufmann.

Related to this story

Topics Asia, China, Medical, Injection Molding

TAOYUAN, TAIWAN — For Taiwanese injection molder SHL Group, a niche focus manufacturing devices for a new class of pricey biologically-based drugs has become big business, to the tune of $140 million invested since 2008.

That includes 75 new molding machines in the last three years, giving the company 175 Krauss Maffei, Engel and Netstal presses. In that time, its workforce has grown from 1,400 employees to more than 2,500.

Taiwan may be better known in industry circles as a hub for the precision manufacturing needed for computers and smartphones, but SHL has tapped that same skill set to become what it says is the world's largest privately owned maker of advanced drug delivery devices.

In particular, the company has grown making injectors and other devices to administer biologics, a class of medicines made biologically, rather than chemically synthesized like traditional drugs.

SHL executives sat down with Plastics News for a recent interview at their headquarters factory in Taoyuan, near Taipei, to talk about how they believe a focus on engineering has helped them be nimble and meet the pharmaceutical industry's quality demands for the new medicines.

"From the founder all the way down, it's all engineers," said General Manager Frank Isaksson. "We have that history. If you go back in time to when we were just a few guys, we've done all that from assembly to tool validation to tool making… That gives an edge."

Beyond competing in the general market for drug injection devices, SHL said it's currently the world's largest maker of auto-injectors to administer drugs for chronic diseases.

Auto-injectors, which inject and retract needles automatically with the push of a button rather than having a patient physically push the needle down as with pen-style injectors, are gaining in popularity with patients who may not have much skill administering their own medication because they need only infrequent injections, said Steven Kaufmann, the company's marketing manager.

As well, the biologic drugs targeted can be expensive, more than $10,000 for a year's supply.

"One of the big things that is driving this industry is we are developing these expensive biologics where we cannot make a mistake when we're taking these types of drugs," he said. "The key [for SHL] is how do we develop these types of ABS-based, mechanical design-based auto injectors that are going to be intuitive for these patient groups."

To help with that, the company has design centers in the United States, Sweden and Taiwan. It won an award from Germany's reddot design competition in 2009 for one its injectors.

While it's definitely established in auto-injectors now, SHL said it took a big gamble when it entered the market in the mid-1990s.

Isaksson said the company, which was started in 1989 in Taiwan by Swedish entrepreneurs Roger Samuelsson and Martin Jelf, saw an opportunity because it felt that existing auto-injector makers were not responsive to the drug industry. So it made the pharmaceutical industry an unusual offer.

"The concept [the drug makers] were offered was the following: you don't pay anything and we will develop, so to say, for free," Isaksson said. "Later on, if you like it, you take it. If not, we are good."

It worked. SHL sold its device, its Peninject 2.25, to Upjohn, now Pfizer, and got its first 510(k) device approval from the U.S. Food and Drug Administration.

Today, the situation's quite the opposite. The company's order book stretches forward years.

As Isaksson guides a visitor around one of its molding rooms, he points out a tray of drug injectors that look ready to be used, but actually won't hit the market until 2017.

With the long product-lead time in the pharmaceutical industry, Isaksson said SHL can predict it will double sales by 2017 or 2018, and will need additional investment beyond the $140 million it's spent in Taiwan since 2008, which included $40 million in 2013.

"Why I'm saying that is that in our pipeline we have so many products coming," he said. "In this industry… nothing happens quickly. That is a benefit. We already now know the drug and the customer and they are in their clinical trials, it's a long process."

SHL spends a lot of time thinking about how to improve its manufacturing. It has hired former employees of its injection molding equipment suppliers to improve its own manufacturing, and a plant tour includes a look at some robotic systems it developed in-house to automate the testing process.

It's using more multi-cavity tools to boost output. And the requirements on its plastics materials are increasing because as drug companies want smaller needles to reduce pain from injections, drugs are being pushed through smaller openings, putting more demands on the plastic, Isaksson said.

The company said it isn't shy about investing in equipment, like buying a much bigger material handling system than it needed with growth and manufacturing flexibility in mind. Isaksson said being privately held and having all the principal owners involved in management — Samuelsson is the chief executive — is an advantage.

"Sometimes we make decisions that if you calculate them on paper it doesn't look like it makes sense in the short term, but we can make decisions that make extremely good sense long-term," Isaksson said.

Given their market's intense requirements, that willingness to invest more than what's needed could be smart economics.

The cost of the company's devices are "so insignificant" compared to the cost of the drugs that the pharmaceutical company's priority is eliminating risk, said Isaksson. A year's supply of one biologic to treat arthritis, for example, can cost more than $20,000.

"The drugs are so expensive that if the injector has a problem, it's a big issue for the drug companies," he said. "If that were to happen, the financial penalties you would have are so severe."

As a result, SHL is actually bringing more of its manufacturing in-house. It makes all of its own springs, because it wanted better control of its manufacturing.

All of its injection molding is in Taiwan, and while it set up a small factory in Florida in for some final assembly, it seems satisfied to keep its plastics-related work in Taiwan. Manufacturing in Taiwan, where it has more than 2,000 employees, is not primarily a low-cost move, said Kaufmann.

"Sometimes people have that misperception that China is cheaper, or Taiwan is cheaper," he said. "Our competitors are in the U.S. and Europe and I would argue in some cases that our prices are equal or more than our competitors but people choose us because of that knowledge and that background.

"We have a lot of our people here and knowledge is at a premium," he said. "I'm not talking just about knowledge of molding or knowledge of tooling but I'm talking about knowledge of molding for medical devices — tooling that's related to auto injectors, automation that's related to auto injectors or pen injectors or inhalers."


Comments

SHL Group grows through medical devices

By Steve Toloken
Staff Reporter / Asia Bureau Chief

Published: February 13, 2014 3:24 pm ET
Updated: February 13, 2014 3:30 pm ET

Post Your Comments


Back to story


More stories

Image

Berry's rebranded Blue Clover expands packaging design reach

January 23, 2015 1:59 pm ET

As design director of Berry Plastics Corp.'s rebranded packaging design studio, Scott Fisher believes the new name of Blue Clover Studios cuts the...    More

Image

Plastics News Now: Plastic helps create smart surfaces in cars

January 22, 2015 6:00 am ET

We check out how plastic is helping lead innovation inside vehicles, a packaging maker is investing in equipment and the "New American Home" features ...    More

Image

Hyundai Mobis investing $24 million to expand in Slovakia

January 22, 2015 9:28 am ET

South Korean auto parts maker Hyundai Mobis has unveiled plans to invest about 21 million euros ($24.1 million) to modernize and expand the output...    More

Image

Pyramid investing in new presses as it targets sales in medical, technical molding

January 21, 2015 1:40 pm ET

Custom molder Pyramid Plastics Inc. is investing to boost its stake in medical and technical molding.    More

China's growth hits 24-year low

January 21, 2015 10:17 am ET

The world's second largest economy reported its 2014 gross domestic product growth at 7.4 percent, the lowest since 1990. The plastics industry exhibi...    More

Market Reports

Plastics in Automotive: Innovation & Emerging Trends

This special report newly released by PN and sponsored by The Conair Group examines current trends in the use of plastics in automotive, materials innovations and the changing landscape. It includes a review of legislative/regulatory activity impacting vehicle development and lightweighting, market opportunities & challenges for mold and toolmakers, innovative design strategies being implemented by major OEMs and suppliers, as well as a review of key indicators in Canada, Mexico, Brazil and China.

Learn more

Plastics Recycling Trends in North America

This report is a review and analysis of the North American Plastics Recycling Industry, including key trends and statistics based on 2013 performance. We examine market environment factors, regulatory issues, industry challenges, key drivers and emerging trends in post-consumer and post-industrial recycling.

Learn more

Injection Molding Market Analysis & Processor Rankings

Plastics News BUNDLED package contains our in-depth Market Analysis of the Injection Molding segment. You will gain keen insight on current trends and our economic outlook.

As a BONUS this includes PN's updated 2014 database of North American Injection Molders RANKED by sales volume. Sort, merge, mail & prospect by end market, materials processed, region, # of plants and more.

Learn more

Upcoming Plastics News Events

February 4, 2015 - February 6, 2015Plastics News Executive Forum 2015

June 2, 2015 - June 3, 2015Plastics Financial Summit - Chicago 2015

September 16, 2015 - September 18, 2015Plastics Caps & Closures - September 2015

More Events